Advertisement MHRA concludes Almac UK site inspection - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

MHRA concludes Almac UK site inspection

Almac has stated that the Medicines and Healthcare products Regulatory Agency (MHRA) has completed the inspection of its Clinical Services UK facility located in Craigavon.

MHRA has concluded that the site continues to be compliant with EU Good Manufacturing Practices, with no critical or major failures observed.

Almac Quality vice president Paul O’Connor said that they were pleased with the outcome of the inspection.

"We have three MHRA approved facilities including our additional FDA assessed US facilities in Audubon, PA & Durham, NC," Connor said.

"The standards of quality compliance will continue with our new $120m North American Headquarters in Souderton scheduled to open during the Fall."